ME-401, A NOVEL, ORAL, POTENT AND SELECTIVE INHIBITOR OF PHOSPHATIDYLINOSITOL 3-KINASE P110δ (PI3Kδ) IN EARLY CLINICAL DEVELOPMENT FOR B-CELL LYMPHOID MALIGNANCIES
Ghalie, R.G., Pagel, J.M., Soumerai, J., Iasonos, A., Patel, K., Moreno, O., Butler, T., Zelenetz, A.D.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2439_184
Date:
June, 2017
File:
PDF, 74 KB
english, 2017